| From Multiple Sclerosis News Today |
A single dose of CD45-ADC, an investigational targeted therapy being developed to treat different types of autoimmune diseases, is enough to reset the normal function of the body’s immune system in a mouse model of multiple sclerosis (MS), and to delay onset of the disease. Those findings were presented earlier this week in the poster […]
The post Single Dose of CD45-ADC Resets the Immune System, Delays the Onset of MS in Mice appeared first on Multiple Sclerosis News Today.
Read on »